Header Logo

Connection

Julie Schneider to Alzheimer Disease

This is a "connection" page, showing publications Julie Schneider has written about Alzheimer Disease.
Connection Strength

23.264
  1. High-throughput digital quantification of Alzheimer disease pathology and associated infrastructure in large autopsy studies. J Neuropathol Exp Neurol. 2023 Nov 20; 82(12):976-986.
    View in: PubMed
    Score: 0.399
  2. Relation of Motor Impairments to Neuropathologic Changes of Limbic-Predominant Age-Related TDP-43 Encephalopathy in Older Adults. Neurology. 2023 10 10; 101(15):e1542-e1553.
    View in: PubMed
    Score: 0.393
  3. Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases. Nat Rev Neurol. 2023 09; 19(9):525-541.
    View in: PubMed
    Score: 0.392
  4. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 2023 07; 146(1):1-11.
    View in: PubMed
    Score: 0.383
  5. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.380
  6. Neuropathology of the Common Forms of Dementia. Clin Geriatr Med. 2023 02; 39(1):91-107.
    View in: PubMed
    Score: 0.370
  7. Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Mol Psychiatry. 2022 10; 27(10):4307-4313.
    View in: PubMed
    Score: 0.369
  8. Neuropathology of Dementia Disorders. Continuum (Minneap Minn). 2022 06 01; 28(3):834-851.
    View in: PubMed
    Score: 0.361
  9. Association of Traumatic Brain Injury With and Without Loss of Consciousness With Neuropathologic Outcomes in Community-Dwelling Older Persons. JAMA Netw Open. 2022 04 01; 5(4):e229311.
    View in: PubMed
    Score: 0.357
  10. Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study. J Alzheimers Dis. 2022; 88(2):653-661.
    View in: PubMed
    Score: 0.351
  11. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons. Acta Neuropathol Commun. 2021 09 25; 9(1):156.
    View in: PubMed
    Score: 0.344
  12. What is 'Alzheimer's disease'? The neuropathological heterogeneity of clinically defined Alzheimer's dementia. Curr Opin Neurol. 2021 04 01; 34(2):237-245.
    View in: PubMed
    Score: 0.333
  13. MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692.
    View in: PubMed
    Score: 0.327
  14. Common Brain Structural Alterations Associated with Cardiovascular Disease Risk Factors and Alzheimer's Dementia: Future Directions and Implications. Neuropsychol Rev. 2020 12; 30(4):546-557.
    View in: PubMed
    Score: 0.322
  15. Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents. Neurology. 2020 10 13; 95(15):e2056-e2064.
    View in: PubMed
    Score: 0.318
  16. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020 10 06; 95(14):e1951-e1962.
    View in: PubMed
    Score: 0.318
  17. Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons. Neurology. 2020 01 14; 94(2):e142-e152.
    View in: PubMed
    Score: 0.303
  18. Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019 12; 86(6):844-852.
    View in: PubMed
    Score: 0.301
  19. Reply: Limbic-predominant age-related TDP-43 encephalopathy (LATE). Brain. 2019 08 01; 142(8):e43.
    View in: PubMed
    Score: 0.296
  20. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019 06 01; 142(6):1503-1527.
    View in: PubMed
    Score: 0.293
  21. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement. 2019 02; 15(2):258-266.
    View in: PubMed
    Score: 0.280
  22. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
    View in: PubMed
    Score: 0.276
  23. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. Acta Neuropathol Commun. 2018 05 01; 6(1):33.
    View in: PubMed
    Score: 0.272
  24. Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2018; 64(s1):S161-S189.
    View in: PubMed
    Score: 0.266
  25. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017 08; 134(2):171-186.
    View in: PubMed
    Score: 0.254
  26. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016 11 01; 139(11):2983-2993.
    View in: PubMed
    Score: 0.245
  27. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.239
  28. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015 Dec 01; 85(22):1930-6.
    View in: PubMed
    Score: 0.229
  29. GSK3? Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res. 2015 Oct; 28(3):232-8.
    View in: PubMed
    Score: 0.224
  30. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.224
  31. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015 Jun; 77(6):942-52.
    View in: PubMed
    Score: 0.220
  32. Reply to Itzhaki and Klapper. J Infect Dis. 2014 Mar; 209(6):974.
    View in: PubMed
    Score: 0.200
  33. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013 Aug 15; 208(4):564-72.
    View in: PubMed
    Score: 0.193
  34. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.185
  35. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012 May 02; 307(17):1798-800.
    View in: PubMed
    Score: 0.179
  36. High blood pressure and microinfarcts: a link between vascular risk factors, dementia, and clinical Alzheimer's disease. J Am Geriatr Soc. 2009 Nov; 57(11):2146-7.
    View in: PubMed
    Score: 0.151
  37. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.148
  38. Neuropathologic intermediate phenotypes enhance association to Alzheimer susceptibility alleles. Neurology. 2009 Apr 28; 72(17):1495-503.
    View in: PubMed
    Score: 0.146
  39. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.128
  40. Early involvement of small inhibitory cortical interneurons in Alzheimer's disease. Acta Neuropathol. 2006 Aug; 112(2):147-62.
    View in: PubMed
    Score: 0.119
  41. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004 Apr 13; 62(7):1148-55.
    View in: PubMed
    Score: 0.103
  42. Sensitivity and Specificity of the Boston Criteria Version 2.0 for the Diagnosis of Cerebral Amyloid Angiopathy in a Community-Based Sample. Neurology. 2024 Jan 09; 102(1):e207940.
    View in: PubMed
    Score: 0.100
  43. Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease. Nat Commun. 2023 Nov 30; 14(1):7659.
    View in: PubMed
    Score: 0.100
  44. Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life. Psychiatry Res. 2023 10; 328:115471.
    View in: PubMed
    Score: 0.099
  45. Associations of Sex, Race, and Apolipoprotein E Alleles With Multiple Domains of Cognition Among Older Adults. JAMA Neurol. 2023 09 01; 80(9):929-939.
    View in: PubMed
    Score: 0.098
  46. Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023 08 01; 146(8):3192-3205.
    View in: PubMed
    Score: 0.098
  47. When Alzheimer's is LATE: Why Does it Matter? Ann Neurol. 2023 08; 94(2):211-222.
    View in: PubMed
    Score: 0.097
  48. Associations of VGF with Neuropathologies and Cognitive Health in Older Adults. Ann Neurol. 2023 08; 94(2):232-244.
    View in: PubMed
    Score: 0.097
  49. Neuropathologic correlates of cerebral microbleeds in community-based older adults. Neurobiol Aging. 2023 09; 129:89-98.
    View in: PubMed
    Score: 0.096
  50. Trends in Postmortem Neurodegenerative and Cerebrovascular Neuropathologies Over 25 Years. JAMA Neurol. 2023 04 01; 80(4):370-376.
    View in: PubMed
    Score: 0.096
  51. Brain ?-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023 02 24; 78(2):277-285.
    View in: PubMed
    Score: 0.095
  52. The status of digital pathology and associated infrastructure within Alzheimer's Disease Centers. J Neuropathol Exp Neurol. 2023 02 21; 82(3):202-211.
    View in: PubMed
    Score: 0.095
  53. Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease. Neurobiol Aging. 2023 06; 126:25-33.
    View in: PubMed
    Score: 0.094
  54. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.094
  55. Association of Stroke and Cerebrovascular Pathologies With Scam Susceptibility in Older Adults. JAMA Neurol. 2023 01 01; 80(1):49-57.
    View in: PubMed
    Score: 0.094
  56. TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups. J Alzheimers Dis. 2023; 91(4):1291-1301.
    View in: PubMed
    Score: 0.094
  57. Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease. J Alzheimers Dis. 2023; 94(1):227-246.
    View in: PubMed
    Score: 0.094
  58. Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. J Alzheimers Dis. 2023; 96(2):683-693.
    View in: PubMed
    Score: 0.094
  59. LATE-NC staging in routine neuropathologic diagnosis: an update. Acta Neuropathol. 2023 02; 145(2):159-173.
    View in: PubMed
    Score: 0.094
  60. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment. JAMA Neurol. 2022 12 01; 79(12):1277-1286.
    View in: PubMed
    Score: 0.093
  61. The Caribbean-Hispanic Alzheimer's disease brain transcriptome reveals ancestry-specific disease mechanisms. Neurobiol Dis. 2023 01; 176:105938.
    View in: PubMed
    Score: 0.093
  62. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
    View in: PubMed
    Score: 0.093
  63. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities. Neurobiol Dis. 2022 Nov; 174:105880.
    View in: PubMed
    Score: 0.092
  64. Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
    View in: PubMed
    Score: 0.092
  65. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain. 2022 08 27; 145(8):2823-2833.
    View in: PubMed
    Score: 0.092
  66. Association of AK4 Protein From Stem Cell-Derived Neurons With Cognitive Reserve: An Autopsy Study. Neurology. 2022 11 15; 99(20):e2264-e2274.
    View in: PubMed
    Score: 0.091
  67. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain. 2022 07 29; 145(7):2541-2554.
    View in: PubMed
    Score: 0.091
  68. Adherence to MIND Diet, Genetic Susceptibility, and Incident Dementia in Three US Cohorts. Nutrients. 2022 Jul 03; 14(13).
    View in: PubMed
    Score: 0.091
  69. RNASE6 is a novel modifier of APOE-e4 effects on cognition. Neurobiol Aging. 2022 10; 118:66-76.
    View in: PubMed
    Score: 0.091
  70. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R2 relaxation rate: an ex-vivo MRI and pathology investigation. Neurobiol Aging. 2022 09; 117:128-138.
    View in: PubMed
    Score: 0.090
  71. FMNL2 regulates gliovascular interactions and is associated with vascular risk factors and cerebrovascular pathology in Alzheimer's disease. Acta Neuropathol. 2022 07; 144(1):59-79.
    View in: PubMed
    Score: 0.090
  72. Caffeine Consumption and Dementia: Are Lewy Bodies the Link? Ann Neurol. 2022 06; 91(6):834-846.
    View in: PubMed
    Score: 0.089
  73. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology. 2022 03 29; 98(13):e1304-e1314.
    View in: PubMed
    Score: 0.089
  74. Genome-wide association study of brain arteriolosclerosis. J Cereb Blood Flow Metab. 2022 08; 42(8):1437-1450.
    View in: PubMed
    Score: 0.088
  75. Progranulin mutations in clinical and neuropathological Alzheimer's disease. Alzheimers Dement. 2022 12; 18(12):2458-2467.
    View in: PubMed
    Score: 0.088
  76. Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease. Stroke. 2022 02; 53(2):404-415.
    View in: PubMed
    Score: 0.088
  77. Improved detection of substantia nigra pathology in Alzheimer's disease. J Histochem Cytochem. 2002 Jan; 50(1):99-106.
    View in: PubMed
    Score: 0.088
  78. Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias. Neurology. 2022 03 08; 98(10):e1031-e1039.
    View in: PubMed
    Score: 0.087
  79. Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease. Biol Psychiatry. 2022 07 01; 92(1):25-33.
    View in: PubMed
    Score: 0.087
  80. Association between WWOX/MAF variants and dementia-related neuropathologic endophenotypes. Neurobiol Aging. 2022 03; 111:95-106.
    View in: PubMed
    Score: 0.087
  81. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.085
  82. ARTS: A novel In-vivo classifier of arteriolosclerosis for the older adult brain. Neuroimage Clin. 2021; 31:102768.
    View in: PubMed
    Score: 0.085
  83. Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics. Neurobiol Aging. 2021 09; 105:99-114.
    View in: PubMed
    Score: 0.084
  84. PLD3 is a neuronal lysosomal phospholipase D associated with ?-amyloid plaques and cognitive function in Alzheimer's disease. PLoS Genet. 2021 04; 17(4):e1009406.
    View in: PubMed
    Score: 0.083
  85. Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons. Brain Pathol. 2021 05; 31(3):e12939.
    View in: PubMed
    Score: 0.083
  86. Regional brain iron associated with deterioration in Alzheimer's disease: A large cohort study and theoretical significance. Alzheimers Dement. 2021 07; 17(7):1244-1256.
    View in: PubMed
    Score: 0.082
  87. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.082
  88. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer's disease. Nat Commun. 2020 11 30; 11(1):6129.
    View in: PubMed
    Score: 0.081
  89. Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline. JAMA Neurol. 2020 10 01; 77(10):1217-1224.
    View in: PubMed
    Score: 0.080
  90. Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia. Cell Rep. 2020 09 01; 32(9):108091.
    View in: PubMed
    Score: 0.080
  91. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.
    View in: PubMed
    Score: 0.079
  92. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020 09; 88(3):513-525.
    View in: PubMed
    Score: 0.079
  93. Scientific Advising and Reviewing: On strengthening the bond between the Alzheimer's Association and the scientific community. Alzheimers Dement. 2020 07; 16(7):1095-1098.
    View in: PubMed
    Score: 0.078
  94. Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain. Nat Neurosci. 2020 06; 23(6):696-700.
    View in: PubMed
    Score: 0.078
  95. Genome-wide interaction analysis of pathological hallmarks in Alzheimer's disease. Neurobiol Aging. 2020 09; 93:61-68.
    View in: PubMed
    Score: 0.078
  96. Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study. Nat Commun. 2020 02 03; 11(1):667.
    View in: PubMed
    Score: 0.077
  97. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease. Nat Med. 2020 01; 26(1):131-142.
    View in: PubMed
    Score: 0.076
  98. Brain Bromine Levels Associated with Alzheimer's Disease Neuropathology. J Alzheimers Dis. 2020; 73(1):327-332.
    View in: PubMed
    Score: 0.076
  99. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.076
  100. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.076
  101. Sleep fragmentation, microglial aging, and cognitive impairment in adults with and without Alzheimer's dementia. Sci Adv. 2019 12; 5(12):eaax7331.
    View in: PubMed
    Score: 0.076
  102. Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):315-320.
    View in: PubMed
    Score: 0.075
  103. Sex differences in the genetic predictors of Alzheimer's pathology. Brain. 2019 09 01; 142(9):2581-2589.
    View in: PubMed
    Score: 0.075
  104. Cognition may link cortical IGFBP5 levels with motor function in older adults. PLoS One. 2019; 14(8):e0220968.
    View in: PubMed
    Score: 0.074
  105. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.074
  106. Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains. J Cell Sci. 2019 07 15; 132(14).
    View in: PubMed
    Score: 0.074
  107. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.074
  108. Sex differences in mixed neuropathologies in community-dwelling older adults. Brain Res. 2019 09 15; 1719:11-16.
    View in: PubMed
    Score: 0.073
  109. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment: A Prospective Cohort Study. Ann Intern Med. 2019 05 21; 170(10):702-709.
    View in: PubMed
    Score: 0.073
  110. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A?, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430.
    View in: PubMed
    Score: 0.072
  111. Risk Aversion and Alzheimer Disease in Old Age. Am J Geriatr Psychiatry. 2019 08; 27(8):851-861.
    View in: PubMed
    Score: 0.072
  112. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry. 2020 11; 25(11):2932-2941.
    View in: PubMed
    Score: 0.072
  113. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease. Acta Neuropathol. 2019 05; 137(5):801-823.
    View in: PubMed
    Score: 0.072
  114. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019 02 19; 92(8):e811-e822.
    View in: PubMed
    Score: 0.071
  115. Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019 01; 15(1):158-167.
    View in: PubMed
    Score: 0.071
  116. Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives. J Alzheimers Dis. 2019; 70(1):153-161.
    View in: PubMed
    Score: 0.071
  117. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann Neurol. 2019 01; 85(1):114-124.
    View in: PubMed
    Score: 0.071
  118. Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains. Nat Neurosci. 2019 01; 22(1):37-46.
    View in: PubMed
    Score: 0.071
  119. In vivo hippocampal subfield shape related to TDP-43, amyloid beta, and tau pathologies. Neurobiol Aging. 2019 02; 74:171-181.
    View in: PubMed
    Score: 0.070
  120. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.070
  121. Seasonal plasticity of cognition and related biological measures in adults with and without Alzheimer disease: Analysis of multiple cohorts. PLoS Med. 2018 09; 15(9):e1002647.
    View in: PubMed
    Score: 0.070
  122. The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain. 2018 09 01; 141(9):2721-2739.
    View in: PubMed
    Score: 0.070
  123. A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research. Sci Data. 2018 08 07; 5:180142.
    View in: PubMed
    Score: 0.069
  124. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol. 2018 08 01; 75(8):989-998.
    View in: PubMed
    Score: 0.069
  125. The Revised National Alzheimer's Coordinating Center's Neuropathology Form-Available Data and New Analyses. J Neuropathol Exp Neurol. 2018 08 01; 77(8):717-726.
    View in: PubMed
    Score: 0.069
  126. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia. Ann Neurol. 2018 07; 84(1):78-88.
    View in: PubMed
    Score: 0.069
  127. Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol. 2018 12; 136(6):857-872.
    View in: PubMed
    Score: 0.069
  128. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018 06; 21(6):811-819.
    View in: PubMed
    Score: 0.068
  129. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 06 12; 90(24):e2127-e2134.
    View in: PubMed
    Score: 0.068
  130. Fractal regulation and incident Alzheimer's disease in elderly individuals. Alzheimers Dement. 2018 09; 14(9):1114-1125.
    View in: PubMed
    Score: 0.068
  131. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable. Alzheimers Dement. 2018 04; 14(4):563-575.
    View in: PubMed
    Score: 0.068
  132. A transcriptomic atlas of aged human microglia. Nat Commun. 2018 02 07; 9(1):539.
    View in: PubMed
    Score: 0.067
  133. Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline. JAMA Neurol. 2017 12 01; 74(12):1473-1480.
    View in: PubMed
    Score: 0.066
  134. Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiol Aging. 2018 02; 62:243.e7-243.e14.
    View in: PubMed
    Score: 0.065
  135. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
    View in: PubMed
    Score: 0.064
  136. Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease. Mol Neurodegener. 2017 07 01; 12(1):51.
    View in: PubMed
    Score: 0.064
  137. Genetic epistasis regulates amyloid deposition in resilient aging. Alzheimers Dement. 2017 Oct; 13(10):1107-1116.
    View in: PubMed
    Score: 0.063
  138. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.062
  139. Financial and Health Literacy Predict Incident Alzheimer's Disease Dementia and Pathology. J Alzheimers Dis. 2017; 56(4):1485-1493.
    View in: PubMed
    Score: 0.062
  140. Risk of incident clinical diagnosis of Alzheimer's disease-type dementia?attributable to pathology-confirmed vascular disease. Alzheimers Dement. 2017 Jun; 13(6):613-623.
    View in: PubMed
    Score: 0.062
  141. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease. Acta Neuropathol. 2017 03; 133(3):395-407.
    View in: PubMed
    Score: 0.061
  142. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res. 2017 03 30; 322(Pt B):233-240.
    View in: PubMed
    Score: 0.061
  143. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies. Neurology. 2016 Aug 02; 87(5):489-96.
    View in: PubMed
    Score: 0.060
  144. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology. Alzheimers Dement. 2016 09; 12(9):942-951.
    View in: PubMed
    Score: 0.059
  145. Association of Seafood Consumption, Brain Mercury Level, and APOE e4 Status With Brain Neuropathology in Older Adults. JAMA. 2016 Feb 02; 315(5):489-97.
    View in: PubMed
    Score: 0.058
  146. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.058
  147. CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015 Nov; 18(11):1556-8.
    View in: PubMed
    Score: 0.057
  148. Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease. Alzheimers Dement. 2016 Feb; 12(2):164-169.
    View in: PubMed
    Score: 0.056
  149. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.056
  150. Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann Neurol. 2015 Aug; 78(2):317-22.
    View in: PubMed
    Score: 0.056
  151. Central role for PICALM in amyloid-? blood-brain barrier transcytosis and clearance. Nat Neurosci. 2015 Jul; 18(7):978-87.
    View in: PubMed
    Score: 0.055
  152. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 2015 May; 129(5):757-62.
    View in: PubMed
    Score: 0.055
  153. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015 Mar; 77(3):469-77.
    View in: PubMed
    Score: 0.055
  154. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16.
    View in: PubMed
    Score: 0.054
  155. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015 Jan; 72(1):15-24.
    View in: PubMed
    Score: 0.054
  156. 24-hour rhythms of DNA methylation and their relation with rhythms of RNA expression in the human dorsolateral prefrontal cortex. PLoS Genet. 2014 Nov; 10(11):e1004792.
    View in: PubMed
    Score: 0.053
  157. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404.
    View in: PubMed
    Score: 0.053
  158. Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of alzheimer dementia and detection of preclinical cortical amyloid. J Neuropathol Exp Neurol. 2014 Oct; 73(10):948-53.
    View in: PubMed
    Score: 0.053
  159. Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet. 2014 Sep; 10(9):e1004606.
    View in: PubMed
    Score: 0.053
  160. Sleep is related to neuron numbers in the ventrolateral preoptic/intermediate nucleus in older adults with and without Alzheimer's disease. Brain. 2014 Oct; 137(Pt 10):2847-61.
    View in: PubMed
    Score: 0.053
  161. Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014 Sep; 17(9):1156-63.
    View in: PubMed
    Score: 0.053
  162. Associations of cerebrovascular and Alzheimer's disease pathology with brain atrophy. Curr Alzheimer Res. 2014 May; 11(4):309-16.
    View in: PubMed
    Score: 0.052
  163. Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement. 2015 Jan; 11(1):32-9.
    View in: PubMed
    Score: 0.051
  164. Ex vivo T2 relaxation: associations with age-related neuropathology and cognition. Neurobiol Aging. 2014 Jul; 35(7):1549-61.
    View in: PubMed
    Score: 0.051
  165. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates. J Neuropathol Exp Neurol. 2014 Jan; 73(1):72-80.
    View in: PubMed
    Score: 0.050
  166. Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014 Jan 21; 82(3):222-9.
    View in: PubMed
    Score: 0.050
  167. Modification of the relationship of the apolipoprotein E e4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol. 2013 Dec; 70(12):1544-51.
    View in: PubMed
    Score: 0.050
  168. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Curr Alzheimer Res. 2013 Oct; 10(8):844-51.
    View in: PubMed
    Score: 0.049
  169. A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging. 2014 Feb; 35(2):301-8.
    View in: PubMed
    Score: 0.049
  170. Genetic susceptibility for Alzheimer disease neuritic plaque pathology. JAMA Neurol. 2013 Sep 01; 70(9):1150-7.
    View in: PubMed
    Score: 0.049
  171. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-e4 carriers. PLoS Genet. 2013; 9(8):e1003685.
    View in: PubMed
    Score: 0.049
  172. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.048
  173. APOE e4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death. Psychol Aging. 2013 Dec; 28(4):1015-23.
    View in: PubMed
    Score: 0.048
  174. Brain amyloid-? oligomers in ageing and Alzheimer's disease. Brain. 2013 May; 136(Pt 5):1383-98.
    View in: PubMed
    Score: 0.048
  175. The complex PrP(c)-Fyn couples human oligomeric A? with pathological tau changes in Alzheimer's disease. J Neurosci. 2012 Nov 21; 32(47):16857-71a.
    View in: PubMed
    Score: 0.047
  176. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012 Nov 06; 79(19):1944-50.
    View in: PubMed
    Score: 0.046
  177. Relation of neuropathology to cognition in persons without cognitive impairment. Ann Neurol. 2012 Oct; 72(4):599-609.
    View in: PubMed
    Score: 0.046
  178. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.046
  179. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.045
  180. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012 Jul; 9(6):646-63.
    View in: PubMed
    Score: 0.045
  181. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8.
    View in: PubMed
    Score: 0.045
  182. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiol Aging. 2013 Jan; 34(1):157-68.
    View in: PubMed
    Score: 0.045
  183. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012 May; 71(5):362-81.
    View in: PubMed
    Score: 0.045
  184. Effect of purpose in life on the relation between Alzheimer disease pathologic changes on cognitive function in advanced age. Arch Gen Psychiatry. 2012 May; 69(5):499-505.
    View in: PubMed
    Score: 0.045
  185. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.045
  186. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement. 2012 Jan; 8(1):1-13.
    View in: PubMed
    Score: 0.044
  187. Correlation of amyloid PET ligand florbetapir F 18 binding with A? aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord. 2012 Jan-Mar; 26(1):8-16.
    View in: PubMed
    Score: 0.044
  188. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 29(3):691-7.
    View in: PubMed
    Score: 0.044
  189. The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease. Aging Cell. 2012 Apr; 11(2):228-33.
    View in: PubMed
    Score: 0.044
  190. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012 Jan; 123(1):1-11.
    View in: PubMed
    Score: 0.043
  191. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Sep; 42(9):2672-713.
    View in: PubMed
    Score: 0.042
  192. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41.
    View in: PubMed
    Score: 0.042
  193. Vulnerability to stress, anxiety, and development of dementia in old age. Am J Geriatr Psychiatry. 2011 Apr; 19(4):327-34.
    View in: PubMed
    Score: 0.042
  194. CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
    View in: PubMed
    Score: 0.041
  195. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet. 2011 Feb 11; 88(2):232-8.
    View in: PubMed
    Score: 0.041
  196. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011 Jan 19; 305(3):275-83.
    View in: PubMed
    Score: 0.041
  197. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.041
  198. Intermediate phenotypes identify divergent pathways to Alzheimer's disease. PLoS One. 2010 Jun 21; 5(6):e11244.
    View in: PubMed
    Score: 0.039
  199. Olfactory impairment in presymptomatic Alzheimer's disease. Ann N Y Acad Sci. 2009 Jul; 1170:730-5.
    View in: PubMed
    Score: 0.037
  200. Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm (Vienna). 2009 May; 116(5):587-97.
    View in: PubMed
    Score: 0.036
  201. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009; 18(3):691-701.
    View in: PubMed
    Score: 0.036
  202. Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology. 2008 Aug 12; 71(7):499-504.
    View in: PubMed
    Score: 0.035
  203. Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimer's disease: relationship to Mini-Mental State Examination scores. Curr Alzheimer Res. 2008 Feb; 5(1):45-51.
    View in: PubMed
    Score: 0.033
  204. Cognitive performance correlates with cortical isopeptide immunoreactivity as well as Alzheimer type pathology. J Alzheimers Dis. 2008 Feb; 13(1):53-66.
    View in: PubMed
    Score: 0.033
  205. Conscientiousness and the incidence of Alzheimer disease and mild cognitive impairment. Arch Gen Psychiatry. 2007 Oct; 64(10):1204-12.
    View in: PubMed
    Score: 0.033
  206. The significance of Pin1 in the development of Alzheimer's disease. J Alzheimers Dis. 2007 Mar; 11(1):13-23.
    View in: PubMed
    Score: 0.031
  207. Loneliness and risk of Alzheimer disease. Arch Gen Psychiatry. 2007 Feb; 64(2):234-40.
    View in: PubMed
    Score: 0.031
  208. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.031
  209. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology. 2006; 27(3):143-53.
    View in: PubMed
    Score: 0.030
  210. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis. 2006 Aug; 9(4):435-43.
    View in: PubMed
    Score: 0.030
  211. The effect of social networks on the relation between Alzheimer's disease pathology and level of cognitive function in old people: a longitudinal cohort study. Lancet Neurol. 2006 May; 5(5):406-12.
    View in: PubMed
    Score: 0.030
  212. The relation of cigarette smoking to incident Alzheimer's disease in a biracial urban community population. Neuroepidemiology. 2006; 26(3):140-6.
    View in: PubMed
    Score: 0.029
  213. Implicit memory and Alzheimer's disease neuropathology. Brain. 2005 Sep; 128(Pt 9):2006-15.
    View in: PubMed
    Score: 0.028
  214. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005 Jun; 62(6):685-91.
    View in: PubMed
    Score: 0.028
  215. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.028
  216. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infarction [corrected] detected at autopsy in older persons. Stroke. 2005 May; 36(5):954-9.
    View in: PubMed
    Score: 0.027
  217. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol. 2004 Mar; 61(3):378-84.
    View in: PubMed
    Score: 0.025
  218. Parkinsonianlike signs and risk of incident Alzheimer disease in older persons. Arch Neurol. 2003 Apr; 60(4):539-44.
    View in: PubMed
    Score: 0.024
  219. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002 Jul; 59(7):1154-60.
    View in: PubMed
    Score: 0.023
  220. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA. 2002 Feb 13; 287(6):742-8.
    View in: PubMed
    Score: 0.022
  221. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol. 2002 Feb; 51(2):182-9.
    View in: PubMed
    Score: 0.022
  222. Alzheimer's Disease-Related Dementias Summit 2019: National Research Priorities for the Investigation of Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease and Related Dementias. J Neurotrauma. 2021 12; 38(23):3186-3194.
    View in: PubMed
    Score: 0.022
  223. The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes. Neurobiol Dis. 2021 09; 157:105428.
    View in: PubMed
    Score: 0.021
  224. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
    View in: PubMed
    Score: 0.020
  225. Genetics of Gene Expression in the Aging Human Brain Reveal TDP-43 Proteinopathy Pathophysiology. Neuron. 2020 08 05; 107(3):496-508.e6.
    View in: PubMed
    Score: 0.020
  226. Total daily physical activity, brain pathologies, and parkinsonism in older adults. PLoS One. 2020; 15(4):e0232404.
    View in: PubMed
    Score: 0.020
  227. Gene expression and DNA methylation are extensively coordinated with MRI-based brain microstructural characteristics. Brain Imaging Behav. 2019 Aug; 13(4):963-972.
    View in: PubMed
    Score: 0.019
  228. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.018
  229. Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults. Neurobiol Aging. 2019 05; 77:104-111.
    View in: PubMed
    Score: 0.018
  230. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.018
  231. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.018
  232. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018 07 24; 13(1):38.
    View in: PubMed
    Score: 0.017
  233. Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
    View in: PubMed
    Score: 0.017
  234. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.017
  235. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry. 2017 11; 88(11):982-994.
    View in: PubMed
    Score: 0.016
  236. Selective lowering of synapsins induced by oligomeric a-synuclein exacerbates memory deficits. Proc Natl Acad Sci U S A. 2017 06 06; 114(23):E4648-E4657.
    View in: PubMed
    Score: 0.016
  237. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med. 2017 04; 14(4):e1002287.
    View in: PubMed
    Score: 0.016
  238. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Ann Neurol. 2017 Apr; 81(4):549-559.
    View in: PubMed
    Score: 0.016
  239. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
    View in: PubMed
    Score: 0.015
  240. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
    View in: PubMed
    Score: 0.015
  241. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.014
  242. Association of APOE with tau-tangle pathology with and without ?-amyloid. Neurobiol Aging. 2016 Jan; 37:19-25.
    View in: PubMed
    Score: 0.014
  243. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging. 2015 Oct; 36(10):2798-805.
    View in: PubMed
    Score: 0.014
  244. a-Synuclein pathology accumulates in sacral spinal visceral sensory pathways. Ann Neurol. 2015 Jul; 78(1):142-9.
    View in: PubMed
    Score: 0.014
  245. Effect of common neuropathologies on progression of late life cognitive impairment. Neurobiol Aging. 2015 Jul; 36(7):2225-2231.
    View in: PubMed
    Score: 0.014
  246. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
    View in: PubMed
    Score: 0.013
  247. Much of late life cognitive decline is not due to common neurodegenerative pathologies. Ann Neurol. 2013 Sep; 74(3):478-89.
    View in: PubMed
    Score: 0.012
  248. APOE e4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8.
    View in: PubMed
    Score: 0.012
  249. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS One. 2011; 6(10):e26286.
    View in: PubMed
    Score: 0.011
  250. Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. J Int Neuropsychol Soc. 2011 Jul; 17(4):602-14.
    View in: PubMed
    Score: 0.011
  251. Cognitive activities during adulthood are more important than education in building reserve. J Int Neuropsychol Soc. 2011 Jul; 17(4):615-24.
    View in: PubMed
    Score: 0.011
  252. Lewy bodies and olfactory dysfunction in old age. Chem Senses. 2011 May; 36(4):367-73.
    View in: PubMed
    Score: 0.010
  253. Estimation of the mediation effect with a binary mediator. Stat Med. 2007 Aug 15; 26(18):3398-414.
    View in: PubMed
    Score: 0.008
  254. Olfactory identification and incidence of mild cognitive impairment in older age. Arch Gen Psychiatry. 2007 Jul; 64(7):802-8.
    View in: PubMed
    Score: 0.008
  255. Thoughts on B-vitamins and dementia. J Alzheimers Dis. 2006 Aug; 9(4):429-33.
    View in: PubMed
    Score: 0.008
  256. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology. 2005; 25(4):163-75.
    View in: PubMed
    Score: 0.007
  257. Cerebral infarctions and the relationship of depression symptoms to level of cognitive functioning in older persons. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):211-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.